In LCNEC, an SCLC subtype with RB1 and TP53 inactivation is recognized as having a low neuroendocrine gene expression profile, with low ASCL1 and high NOTCH gene expression (referred to as type II LCNEC). This evidence concerns the gene ASCL1 and small cell lung carcinoma.